NCT03223610
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,264 public trials
216 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
NCT05757219
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04094311
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- Novartis Investigative Site Hamilton, Ontario, Canada
- Novartis Investigative Site Ottawa, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
NCT07195916
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- The University of Nebraska Medical Center Omaha, Nebraska, United States
NCT07817641
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- Dept. of oncology Copenhagen, Select A State, Denmark
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
NCT06806033
- Conditions
- Cytokine Release Syndrome, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States
NCT05934084
- Conditions
- Behavior, Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), +13 more
- Locations
-
- Ancona - AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
- Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
- Istituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare Bari, Italy
- Ospedale S. Martino - UOC Oncologia Belluno, Italy
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States